Loading...
Keywords
Last Name
Institution

Connection

Search Results to Matthew J. McLaughlin

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of McLaughlin, Matthew

PropertyValue
research overview Matt McLaughlin is a Pediatric Rehabilitation Medicine physician and Clinical Pharmacologist. His primary research centers on optimizing “the right medication for the right patient at the right time to improve outcomes.” He completed the MD/BA 6-year program at the University of Missouri-Kansas City prior to starting his fellowship at the University of Missouri-Columbia. After graduation from residency, he pursued a clinical Pediatric Rehabilitation Medicine fellowship at Children’s Mercy Hospital in Kansas City. During this time, he obtained his Masters in Medical Bioinformatics to help with clinical research design and database management. Upon graduation, he was named a Vice Chancellors Honors Recipient for obtaining a 4.0 GPA while also positively contributing to the Kansas City community. He received advance training in Clinical Pharmacology by participating in an NICHD T32 Fellowship in Pediatric Clinical and Developmental Pharmacology prior to starting his K12 funding. Dr. McLaughlin’s primary research work has centered around precision medicine in pediatric patients with cerebral palsy (CP). Clinically, he remains passionate about how to employ the pharmacogenetics associated with alterations in medication absorption, distribution, elimination and metabolism with improving clinical outcomes. He employs aspects of pharmacokinetic modeling, pharmacogenomics and clinical trial design in his studies. His work earned him the Best Original Research Article by a Young Physician by the PM&R Journal in 2018. He is currently an Associate Professor in the Department of Pediatrics at Children’s Mercy – Kansas City.

One or more keywords matched the following items that are connected to McLaughlin, Matthew

Item TypeName
Concept Adenosine Monophosphate
Concept Alanine
Concept Amantadine
Concept Antimalarials
Concept Antiviral Agents
Concept Baclofen
Concept Dose-Response Relationship, Drug
Concept Drug Administration Schedule
Concept Hydroxychloroquine
Concept Injections
Concept Mandelic Acids
Concept Muscle Relaxants, Central
Concept Neuromuscular Agents
Concept Stereoisomerism
Concept Drug Delivery Systems
Concept Drug Monitoring
Concept Botulinum Toxins, Type A
Concept Papillomavirus Vaccines
Concept Drug Discovery
Concept Sulfonylurea Receptors
Concept Drug-Related Side Effects and Adverse Reactions
Academic Article Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children With Cerebral Palsy.
Academic Article The Interplay between Pharmacokinetics and Pharmacodynamics.
Academic Article Considerations for Implementing Precision Therapeutics for Children.
Grant Genomic- and Ontogeny-Linked Dose Individualization and cLinical Optimization for Kids
Grant Neurorehabilitation and Restorative Neuroscience Network
Academic Article Simultaneous Quantitation of S(+)- and R(-)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC-APCI-MS/MS: An Application for Clinical Studies.
Academic Article Safe and effective medication utilization in pediatric patients requiring rehabilitation services during the Coronavirus pandemic of 2019.
Academic Article A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19).

Search Criteria
  • Drug
  • Development